Search Results - "Zhu, A.X."

VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial by Kelley, R.K., Yau, T., Cheng, A.-L., Kaseb, A., Qin, S., Zhu, A.X., Chan, S., Sukeepaisarnjaroen, W., Breder, V., Verset, G., Gane, E., Borbath, I., Gomez Rangel, J.D., Merle, P., Benzaghou, F.M., Banerjee, K., Hazra, S., Fawcett, J., Rimassa, L.

Get full text

THU-16 Systemic therapies for cholangiocarcinoma: State of the art 2013 by Zhu, A.X

Get full text

NRG/RTOG 1112: Randomized Phase III Study of Sorafenib vs. Stereotactic Body Radiation Therapy (SBRT) Followed by Sorafenib in Hepatocellular Carcinoma (HCC) (NCT01730937) by Dawson, L.A., Winter, K., Knox, J., Zhu, A.X., Krishnan, S., Guha, C., Kachnic, L.A., Gillin, M.T., Hong, T.S., Craig, T., Hosni, A., Chen, E., Noonan, A., Koay, E.J., Sinha, R., Lock, M.I., Ohri, N., Dorth, J.A., Moughan, J., Crane, C.H.

“…The role of SBRT in the treatment of HCC is not well established. The hypothesis of this study was that overall survival (OS) would improve with SBRT followed…”
Get full text

Outcomes After Liver Directed Radiation Therapy for Hepatocellular Carcinoma With Tumor Venous Thrombosis by Keane, F.K, Wo, J.Y, Wolfgang, J.A, Goyal, L, Blaszkowsky, L.S, Zhu, A.X, Hong, T.S

Get full text

Interfractional and Immobilization Related Respiratory Motion Variability for Treatment of Liver Tumors by Vieira, B. Lavajo, Kosak, T.K, Belkacemi, Y, Wo, J.Y, Zhu, A.X, Hong, T.S, Wolfgang, J.A

Get full text

Tolerability of Liver Re-irradiation With Stereotactic Radiation Therapy by Raldow, A, Wo, J.Y, Wolfgang, J.A, Zhu, A.X, Hong, T.S

Get full text

Treatment-Induced Changes in Circulating Lymphocyte Populations Associate With Survival of Patients With Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (ICC) Treated With Hypofractionated Proton Therapy (HPT) by Grassberger, C, Wo, J.Y, Hato, T, Bortfeld, T, Wolfgang, J.A, Zhu, A.X, Duda, D.G, Hong, T.I

Get full text

Putative role of ischemic postconditioning in a rat model of limb ischemia and reperfusion: involvement of hypoxia-inducible factor-1[alpha] expression by Wang, T, Zhou, Y.T, Chen, X.N, Zhu, A.X

“…Hypoxia-inducible factor-1a (HIF-1[alpha]) is one of the most potent angiogenic growth factors. It improves angiogenesis and tissue perfusion in ischemic…”
Get full text

Early Response Assessment After Hypofractionated Proton Radiation Therapy for Primary Liver Tumors by Tanguturi, S, Kambadakone, A, Niemierko, A, Nguyen, K.N, Wo, J.Y, Blaszkowsky, L.S, Goyal, L, Wolfgang, J.A, Zhu, A.X, Hong, T.S

Get full text

Impact of Intravenous Contrast Enhancement Phase on Target Definition for Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (IHC): Observations From Patients Enrolled on a Prospective Phase 2 Trial by Niska, J.R, Wolfgang, J.A, Hahn, P.F, Wo, J.Y, Zhu, A.X, Hong, T.S

Get full text

Assessment of soil erosion and conservation on agricultural sloping lands using plot data in the semi-arid hilly loess region of China by Zhu, T.X., Zhu, A.X.

“…•We examine runoff and soil loss at slope angles up to 30°.•We compare runoff and soil loss from short and long slopes.•We evaluate soil and water loss caused…”
Get full text

Change in Platelet Count and Normal Liver Dosimetry in Patients Receiving Proton Radiation Therapy for Unresectable Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma by Dyer, M.A, McDonnell, E.I, Yeap, B.Y, Depauw, N, Wolfgang, J.A, Wo, J.Y, DeLaney, T.F, Ben-Josef, E, Crane, C.H, Zhu, A.X, Hong, T.I

Get full text

P93 HYPOXIA UNDER SORAFENIB TREATMENT UPREGULATES SDF1a/CXCR4 RESULTING IN MYOFIBROBLAST ACTIVATION, GR1+ CELL INFILTRATION, AND DESMOPLASIA IN HEPATOCELLULAR CARCINOMA by Reiberger, T, Chen, Y, Huang, P, Lauwers, G.Y, Zhu, A.X, Jain, R.K, Duda, D.G

Get full text

Influence of Body Mass Index (BMI) on Colorectal Cancer Mutation Status by Kamran, S.C, Russo, A.L, Borger, D.R, Szymonifka, J, Kwak, E.L, Clark, J.W, Blaszkowsky, L.S, Ryan, D.P, Allen, J.N, Wo, J.Y, Zhu, A.X, Iafrate, A, Haigis, K.M, Hong, T.S

Get full text

Clinical and Molecular Predictors of Local Failure After SBRT for Liver Metastases: A Secondary Analysis of a Prospective Phase II Trial by Wo, J.Y, Zhu, A.X, McDonnell, E.I, Yeap, B, Borger, D.R, Iafrate, A, Drapek, L.C, Blaszkowsky, L.S, Kwak, E.L, Clark, J, Goyal, L, Allen, J.N, Ryan, D.P, Arellano, R, Wolfgang, J.A, Mullen, J.T, Mamon, H.J, DeLaney, T.F, Hong, T.S

Get full text

A Single Arm Phase 2 Study of Individualized Proton-Based Stereotactic Body Radiation Therapy (P-SBRT) of Liver Metastases by Hong, T.S, Wo, J.Y, McDonnell, E.I, Yeap, B, Drapek, L.C, Wolfgang, J.A, Blaszkowsky, L.S, Kwak, E.L, Clark, J, Tanguturi, S, Goyal, L, Allen, J.N, Ryan, D.P, Arellano, R, Mullen, J.T, Mamon, H.J, DeLaney, T.F, Zhu, A.X

Get full text

P0288 : CXCR4 inhibition reverts immunosuppressive tumor microenvironment and facilitates Anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma by Reiberger, T, Yunching, C, Ramjiawan, R.R, Ng, R.R, Hato, T, Huang, Y, Unan, E.C, Reddy, T.P, Fan, C, Huang, P, Bardeesy, N, Zhu, A.X, Jain, R.K, Duda, D.G

Get full text

Mutational Profile of Gastroesophageal Cancer Compared to Gastric and Esophageal Cancers by Russo, A.L, Kwak, E.L, Borger, D.R, Szymonifka, J, Mullen, J.T, Zhu, A.X, Blaszkowsky, L.S, Wo, J.Y, Ryan, D.P, Hong, T.S

Get full text

Patient Tolerability and Acute Toxicity of Intensity Modulated Radiation Therapy for Treatment of Carcinomas of the Biliary Tract by Braunstein, L.Z, Zhu, A.X, Wo, J.Y, Ancukiewicz, M, Napolitano, B.N, Wolfgang, J.A, Mamon, H.J, Blaszkowsky, L.S, Ryan, D.P, Hong, T.S

Get full text

Pembrolizumab vs best supportive care for second-line advanced hepatocellular carcinoma: Randomized, phase 3 KEYNOTE-240 study by Finn, R., Chan, S.L., Zhu, A.X., Knox, J., Cheng, A.-L., Siegel, A., Bautista, O., Watson, P.A., Kudo, M.

Get full text